The analysis of the association of the polymorphic variants of the TPMT, COMT, and ABCC3 genes with the development of hearing disorders induced by the cisplatin treatment
- 1 January 2018
- journal article
- Published by Media Sphere Publishing Group in Vestnik otorinolaringologii
- Vol. 83 (4), 60-66
- https://doi.org/10.17116/otorino201883460
Abstract
Medical article медицинская статьяThis publication has 25 references indexed in Scilit:
- Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatinPharmacogenomics, 2017
- Cisplatin and Aminoglycoside Antibiotics: Hearing Loss and Its PreventionThe Anatomical Record, 2012
- Ototoxicity From Cisplatin Therapy in Childhood CancerJournal of Pediatric Hematology/Oncology, 2007
- Ototoxicity from high‐dose use of platinum compounds in patients with neuroblastomaCancer, 2006
- Ototoxicity in Children Receiving Platinum Chemotherapy: Underestimating a Commonly Occurring Toxicity That May Influence Academic and Social DevelopmentJournal of Clinical Oncology, 2005
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005
- Predicting cisplatin ototoxicity in children: the influence of age and the cumulative doseEuropean Journal of Cancer, 2004
- Platinum Compound-Related Ototoxicity in ChildrenJournal of Pediatric Hematology/Oncology, 2004
- Cisplatin: mode of cytotoxic action and molecular basis of resistanceOncogene, 2003
- Risk Factors for Ototoxicity due to CisplatinJAMA Otolaryngology–Head & Neck Surgery, 1994